Zevra Therapeutics, Inc. Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments
Zevra Therapeutics, Inc. (ZVRA) had Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments of $610.00 thousand as of 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments · last filed 2019-03-01
- 2018-12-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $610.00K.
- 2017-12-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $751.00K.
- 2016-12-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $813.00K.
- 2015-12-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $26.00K.
| Period end | Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments |
|---|---|
| 2018-12-31 | $610.00K 10-K · filed 2019-03-01 |
| 2017-12-31 | $751.00K 10-K · filed 2018-03-30 |
| 2016-12-31 | $813.00K 10-K · filed 2017-03-10 |
| 2015-12-31 | $26.00K 10-K · filed 2016-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |